Its lead programs target thymic stromal lymphopoietin and interleukin-13 and are in clinical development. Windward Bio Group AG is a Swiss clinical-stage biotechnology company founded in 2024 that develops ultra-long-acting monoclonal antibodies for serious respiratory and dermatologic immunological diseases, including asthma, chronic obstructive pulmonary disease, and atopic dermatitis.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Windward Bio Group AG market cap is $1.65B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Windward Bio Group AG 52 week high is $33.99 as of November 15, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Windward Bio Group AG 52 week low is $17.00 as of November 15, 2026.
Windward Bio Group AG stock price today is $28.50.
Windward Bio Group AG stock price yesterday was $17.00.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Windward Bio Group AG's P/E ratio is -3.84.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Windward Bio Group AG P/B ratio is 1.6561.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Windward Bio Group AG 50-day moving average is $22.75.
